Shares of Vera Therapeutics (VERA) sold off about 20% on Friday following news in competitor Otsuka’s 2024 earnings presentation that the ...

In our presentation today ... We continue to believe that it is important to evaluate Evercore's performance on an annual basis. As we've noted previously, our results for any particular quarter ...

An intriguing battle is brewing in the market to treat patients with transthyretin amyloid cardiomyopathy (ATTR-CM). | BridgeBio reported that 1,028 unique prescriptions have been written by 516 ...

In our presentation today ... We continue to believe that it is important to evaluate Evercore's performance on an annual basis. As we have noted previously, our results for any particular ...

Q4 2024 Earnings Call February 20, 2025 8:30 AM ETCompany ParticipantsAshley Curtis - Assistant VP of IRStephen Yalof - President ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.OtgQHJex.js ...

US-listed product tanker owners were taking on more losses in early trading Friday after a bloody Thursday that saw two top ...

For Vertex these days, it’s all about the launches of three new products—sickle cell disease gene therapy Casgevy, the ...

Manager, IR: Maria Pope – President and CEO: Joe Trpik – SVP, Finance and CFO: Julien Dumoulin-Smith – Jefferies: Richard ...

As the company’s sales fell 6 percent in the second quarter, the owner of namesake Estée Lauder, Jo Malone, Tom Ford, Clinique and more, announced plans to ramp up its restructuring program, from ...

Q4 2024 Earnings Call Transcript February 3, 2025 Operator: Good morning, and welcome to the Saia Incorporated Fourth Quarter 2024 Earnings Conference Call. All participants will be in listen-only ...